Levels of F-2 isoprostane in Behcet's disease: Correlation with cardiometabolic risk factors

Sagun G., OĞUZ A., Mesci B., Isbilen B., Kavala M., KESKİN H., ...Daha Fazla

REDOX REPORT, cilt.20, sa.5, ss.223-227, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20 Sayı: 5
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1179/1351000215y.0000000008
  • Dergi Adı: REDOX REPORT
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.223-227
  • Anahtar Kelimeler: Behcet's disease, F-2 isoprostane, Cardiometabolic risk factors, CORONARY-ARTERY CALCIFICATION, SYSTEMIC-LUPUS-ERYTHEMATOSUS, OXIDATIVE STRESS, LIPID-PEROXIDATION, CARDIOVASCULAR-DISEASE, IN-VIVO, F-2-ISOPROSTANES, SCLERODERMA, F2-ALPHA, MARKERS
  • Ankara Üniversitesi Adresli: Hayır

Özet

Objective: Behcet's disease (BD) is a chronic inflammatory disease and recent findings suggest a role of oxidative stress in the pathogenesis of BD. Free radical-induced oxidative stress is also involved in the pathogenesis of cardiovascular and other rheumatic diseases. Oxidative stress may be detected in vivo by measuring F-2 isoprostanes. Here, we measured plasma levels of F-2 isoprostane in patients with BD and evaluated the correlation of F-2 isoprostane with cardiometabolic risk factors.